Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd has announced the quotation of 2,958 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective May 29, 2025. This development is part of the company’s strategic financial activities, potentially enhancing its capital structure and providing more flexibility for future growth initiatives. The issuance of these securities may impact the company’s market positioning by increasing its visibility and attractiveness to investors.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is primarily involved in creating innovative treatments for various types of cancer, aiming to improve patient outcomes and address unmet medical needs in the oncology market.
Average Trading Volume: 136,894
Technical Sentiment Signal: Buy
Current Market Cap: A$237.1M
See more insights into RAC stock on TipRanks’ Stock Analysis page.